Pierre... And to think, we also have "world-wide patent rights" for PBT2 facilitating antibiotic efficacy against bacterial infections. I guess we're all sitting in the catbird seat except for the long wait for something tangible to happen in our lifetime.
Ann: New US patent targeting major neurodegenerative diseases, page-7
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $45 | 12.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 22140821 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 130756600 | 30 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |